Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Soo-Yun Lee, Wooseong Huh, Jin Ah Jung, Hye Min Yoo, Jae-Wook Ko & Jung-Ryul Kim. (2015) Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid. Drug Design, Development and Therapy 9, pages 4559-4563.
Read now
Read now
Holger Sterzik, Alejandro Soriano, Al-Montaser Mohamad, José Antonio Martínez, Javier Fernandez, Nazaret Cobos, Laura Morata & Josep Mensa. (2011) Is linezolid a risk factor for Gram-negative bacillus infections in intensive care unit patients? A comparative study with vancomycin. Scandinavian Journal of Infectious Diseases 43:10, pages 765-770.
Read now
Read now
Fatemeh Rafii, John B Sutherland & Carl E Cerniglia. (2008) Effects of treatment with antimicrobial agents on the human colonic microflora. Therapeutics and Clinical Risk Management 4:6, pages 1343-1358.
Read now
Read now
G Samonis, S Maraki, E Barbounakis, K Leventakos, G Lamaris, M Rovithi, I Hatjiioannou, E Potolidis, Y Tselentis & E Mantadakis. (2006) Effects of vancomycin, teicoplanin, linezolid, quinupristin-dalfopristin, and telithromycin on murine gut colonization by Candida albicans. Medical Mycology 44:2, pages 193-196.
Read now
Read now
L. Lazzarini & F. De Lalla. (2003) Failure of Intravenous Linezolid to Treat Clostridium difficile Associated Diarrhea. Journal of Chemotherapy 15:3, pages 299-300.
Read now
Read now
Articles from other publishers (62)
Hadil Alahdal, Ghaida Almuneef, Manal Muhammed Alkhulaifi, Omar Aldibasi, Abdulrahman Aljouie, Othman Alharbi, Zakiah Naser Almohawes, Fatemah Basingab & Mokhtar Rejili. (2024) Gut microbiota composition in patients with Crohn’s disease in Saudi Arabia. PLOS ONE 19:4, pages e0299749.
Crossref
Crossref
Son-Nam H. Le, Chau Nguyen Ngoc Minh, Paola Florez de Sessions, Song Jie, Chau Tran Thi Hong, Guy E. Thwaites, Stephen Baker, Duy Thanh Pham & Hao Chung The. (2024) The impact of antibiotics on the gut microbiota of children recovering from watery diarrhoea. npj Antimicrobials and Resistance 2:1.
Crossref
Crossref
J Nowakowska, D R Cameron, A De Martino, J Kühn, S Le Fresne-Languille, S Leuillet, Y Amouzou, F Wittke, T Carton, F Le Vacon, R L Chaves, V Nicolas-Metral & G Vuagniaux. (2023) Evaluation of the microbiota-sparing properties of the anti-staphylococcal antibiotic afabicin. Journal of Antimicrobial Chemotherapy 78:8, pages 1900-1908.
Crossref
Crossref
Edward Ishiguro, Natasha Haskey & Kristina Campbell. 2023. Gut Microbiota. Gut Microbiota
83
104
.
Keeley O’Grady, Daniel R. Knight & Thomas V. Riley. (2021) Antimicrobial resistance in Clostridioides difficile. European Journal of Clinical Microbiology & Infectious Diseases 40:12, pages 2459-2478.
Crossref
Crossref
Emna Gaies, Ikram Fazaa, Mouna Ben Sassi, Rim Charfi, Nadia Jebabli, Hanene El Jebari, Riadh Daghfous & Sameh Trabelsi. (2021) Drug-drug interactions between two beta-lactam antibiotics and valproic acid in the same patient. Therapies 76:5, pages 475-477.
Crossref
Crossref
Nader S. Abutaleb, Ahmed E.M. Elhassanny, Daniel P. Flaherty & Mohamed N. Seleem. (2021) In vitro and in vivo activities of the carbonic anhydrase inhibitor, dorzolamide, against vancomycin-resistant enterococci. PeerJ 9, pages e11059.
Crossref
Crossref
Nader S. Abutaleb, Ahmed Elkashif, Daniel P. Flaherty & Mohamed N. Seleem. (2021)
In Vivo
Antibacterial Activity of Acetazolamide
. Antimicrobial Agents and Chemotherapy 65:4.
Crossref
Crossref
Vijaya T. Daniel, Stephanie Francalancia, Nili S. Amir, M. Didem Ayturk, Stacy B. Sanders, Jonathan R Wisler, Courtney E. Collins, Doyle V. Ward, Catarina I. Kiefe, Beth A. McCormick & Heena P. Santry. (2020) Upper Gastrointestinal Perforations: A Possible Danger of Antibiotic Overuse. Journal of Gastrointestinal Surgery 24:12, pages 2730-2736.
Crossref
Crossref
Karen T Elvers, Victoria J Wilson, Ashley Hammond, Lorna Duncan, Alyson L Huntley, Alastair D Hay & Esther T van der Werf. (2020) Antibiotic-induced changes in the human gut microbiota for the most commonly prescribed antibiotics in primary care in the UK: a systematic review. BMJ Open 10:9, pages e035677.
Crossref
Crossref
Patrice Nordmann, Angel Rodríguez-Villodres & Laurent Poirel. (2019) A selective culture medium for screening linezolid-resistant gram-positive bacteria. Diagnostic Microbiology and Infectious Disease 95:1, pages 1-4.
Crossref
Crossref
David A Muñiz Pedrogo, Jun Chen, Benjamin Hillmann, Patricio Jeraldo, Gabriel Al-Ghalith, Veena Taneja, John M DavisIIIIII, Dan Knights, Heidi Nelson, William A Faubion, Laura Raffals & Purna C Kashyap. (2019) An Increased Abundance of Clostridiaceae Characterizes Arthritis in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Cross-sectional Study. Inflammatory Bowel Diseases 25:5, pages 902-913.
Crossref
Crossref
Yoav Golan. (2019) Current Treatment Options for Acute Skin and Skin-structure Infections. Clinical Infectious Diseases 68:Supplement_3, pages S206-S212.
Crossref
Crossref
Esther Neelis, Barbara de Koning, Edmond Rings, René Wijnen, Ben Nichols, Jessie Hulst & Konstantinos Gerasimidis. (2018) The Gut Microbiome in Patients with Intestinal Failure: Current Evidence and Implications for Clinical Practice. Journal of Parenteral and Enteral Nutrition 43:2, pages 194-205.
Crossref
Crossref
Haroon Mohammad, Ahmed AbdelKhalek, Nader S. Abutaleb & Mohamed N. Seleem. (2018) Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci. International Journal of Antimicrobial Agents 51:6, pages 897-904.
Crossref
Crossref
Suma Sarojini. 2018. Diet, Microbiome and Health. Diet, Microbiome and Health
1
31
.
Edward Ishiguro, Natasha Haskey & Kristina Campbell. 2018. Gut Microbiota. Gut Microbiota
91
104
.
Miika Arvonen, Lillemor Berntson, Tytti Pokka, Tuomo J Karttunen, Paula Vähäsalo & Matthew L Stoll. (2016) Gut microbiota-host interactions and juvenile idiopathic arthritis. Pediatric Rheumatology 14:1.
Crossref
Crossref
Ben Boursi, Kevin Haynes, Ronac Mamtani & Yu-Xiao Yang. (2015) Impact of antibiotic exposure on the risk of colorectal cancer. Pharmacoepidemiology and Drug Safety 24:5, pages 534-542.
Crossref
Crossref
Andrew F. Shorr, Thomas P. Lodise, G. Ralph Corey, Carisa De Anda, Edward Fang, Anita F. Das & Philippe Prokocimer. (2015) Analysis of the Phase 3 ESTABLISH Trials of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections. Antimicrobial Agents and Chemotherapy 59:2, pages 864-871.
Crossref
Crossref
Hyeun Bum Kim, Quanshun Zhang, Xingmin Sun, Gillian Beamer, Yuankai Wang & Saul Tzipori. (2014) Beneficial Effect of Oral Tigecycline Treatment on Clostridium difficile Infection in Gnotobiotic Piglets. Antimicrobial Agents and Chemotherapy 58:12, pages 7560-7564.
Crossref
Crossref
J. König & R.J. Brummer. (2014) Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome. Beneficial Microbes 5:3, pages 247-262.
Crossref
Crossref
Mamun-Ur Rashid, Axel Dalhoff, Tobias Bäckström, Linda Björkhem-Bergman, Georgios Panagiotidis, Andrej Weintraub & Carl Erik Nord. (2014) Ecological impact of MCB3837 on the normal human microbiota. International Journal of Antimicrobial Agents 44:2, pages 125-130.
Crossref
Crossref
N. Bourgeois-Nicolaos, T. T. Nguyen, G. Defrance, L. Massias, L. Alavoine, A Lefort, V. Noel, E. Senneville, F. Doucet-Populaire, F. Mentré, A. Andremont & X. Duval. (2014) The Emergence of Linezolid Resistance among Enterococci in Intestinal Microbiota of Treated Patients Is Unrelated to Individual Pharmacokinetic Characteristics. Antimicrobial Agents and Chemotherapy 58:5, pages 2681-2687.
Crossref
Crossref
Ana María Sánchez-DíazClaudio CuarteroSara LozanoJuan Diego RodríguezJuan Manuel AlonsoInmaculada Quiles-MeleroJavier LópezRafael CantónPatricia Ruiz-Garbajosa. (2014)
Emergence and Long-Lasting Persistence of Linezolid-Resistant
Enterococcus faecium-
ST117 in an Oncohematologic Patient After a Nine-Day Course of Linezolid
. Microbial Drug Resistance 20:1, pages 17-21.
Crossref
Crossref
Julia König & Robert-Jan Brummer. 2014. Pharma-Nutrition. Pharma-Nutrition
55
73
.
Gwen Duytschaever, Geert Huys, Linda Boulanger, Kris De Boeck & Peter Vandamme. (2013) Amoxicillin–clavulanic acid resistance in fecal Enterobacteriaceae from patients with cystic fibrosis and healthy siblings. Journal of Cystic Fibrosis 12:6, pages 780-783.
Crossref
Crossref
Zhi-juan WU, Xi DU & Jian ZHENG. (2013) Role of Lactobacillus in the prevention of Clostridium difficile -associated diarrhea: a meta-analysis of randomized controlled trials. Chinese Medical Journal 126:21, pages 4154-4161.
Crossref
Crossref
Emmanouil Angelakis, Vicky Merhej & Didier Raoult. (2013) Related actions of probiotics and antibiotics on gut microbiota and weight modification. The Lancet Infectious Diseases 13:10, pages 889-899.
Crossref
Crossref
Germander Soothill, Yanmin Hu & Anthony Coates. (2013) Can We Prevent Antimicrobial Resistance by Using Antimicrobials Better?. Pathogens 2:2, pages 422-435.
Crossref
Crossref
Gwen Duytschaever, Geert Huys, Maarten Bekaert, Linda Boulanger, Kris De Boeck & Peter Vandamme. (2013) Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota. Journal of Cystic Fibrosis 12:3, pages 206-215.
Crossref
Crossref
Irène Mangin, Christophe Lévêque, Fabien Magne, Antonia Suau & Philippe Pochart. (2012) Long-Term Changes in Human Colonic Bifidobacterium Populations Induced by a 5-Day Oral Amoxicillin-Clavulanic Acid Treatment. PLoS ONE 7:11, pages e50257.
Crossref
Crossref
C. H. Chilton, J. Freeman, G. S. Crowther, S. L. Todhunter, S. Nicholson & M. H. Wilcox. (2012) Co-amoxiclav induces proliferation and cytotoxin production of Clostridium difficile ribotype 027 in a human gut model. Journal of Antimicrobial Chemotherapy 67:4, pages 951-954.
Crossref
Crossref
Florian M.E. Wagenlehner, Björn Wullt & Gianpaolo Perletti. (2011) Antimicrobials in urogenital infections. International Journal of Antimicrobial Agents 38, pages 3-10.
Crossref
Crossref
S. D. Baines, A. R. Noel, G. S. Huscroft, S. L. Todhunter, R. O'Connor, J. K. Hobbs, J. Freeman, A. M. Lovering & M. H. Wilcox. (2011) Evaluation of linezolid for the treatment of Clostridium difficile infection caused by epidemic strains using an in vitro human gut model. Journal of Antimicrobial Chemotherapy 66:7, pages 1537-1546.
Crossref
Crossref
Caitlin R. Musgrave, P. Brandon Bookstaver, S. Scott Sutton & April D. Miller. (2011) Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection. International Journal of Infectious Diseases 15:7, pages e438-e448.
Crossref
Crossref
T. Mathur, M. Kumar, T. K. Barman, G. R. Kumar, V. Kalia, S. Singhal, V. S. Raj, D. J. Upadhyay, B. Das & P. K. Bhatnagar. (2011) Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile. Journal of Antimicrobial Chemotherapy 66:5, pages 1087-1095.
Crossref
Crossref
H. K. F. van Saene, N. J. Reilly, A. de Silvestre & F. Rios. 2012. Infection Control in the Intensive Care Unit. Infection Control in the Intensive Care Unit
173
187
.
I. Mangin, A. Suau, M. Gotteland, O. Brunser & P. Pochart. (2010) Amoxicillin treatment modifies the composition of Bifidobacterium species in infant intestinal microbiota. Anaerobe 16:4, pages 433-438.
Crossref
Crossref
Catherina J. M. Koning, Daisy Jonkers, Hauke Smidt, Frans Rombouts, Herman-Jan Pennings, Emiel Wouters, Ellen Stobberingh & Reinhold Stockbrügger. (2009) The effect of a multispecies probiotic on the composition of the faecal microbiota and bowel habits in chronic obstructive pulmonary disease patients treated with antibiotics. British Journal of Nutrition 103:10, pages 1452-1460.
Crossref
Crossref
J. D. Chalmers, M. Al-Khairalla, P. M. Short, T. C. Fardon & J. H. Winter. (2010) Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic. Journal of Antimicrobial Chemotherapy 65:4, pages 608-618.
Crossref
Crossref
M. Khoder, N. Tsapis & E. Fattal. (2010) Mechanisms of antibiotic resistance and delivery strategies to prevent its emergence. Journal of Drug Delivery Science and Technology 20:6, pages 407-418.
Crossref
Crossref
N. Bourgeois-Nicolaos & F. Doucet-Populaire. (2010) Oxazolidinones. EMC - Maladies infectieuses 7:2, pages 1-13.
Crossref
Crossref
Diamantis P. Kofteridis, Polychronis Malliotakis, Sofia Maraki, Maria Christofaki & George Samonis. (2009) Impact of prolonged treatment with linezolid on the human gut flora. International Journal of Infectious Diseases 13:5, pages e313-e315.
Crossref
Crossref
N. Bourgeois-Nicolaos, C. Guillet-Caruba & F. Doucet-Populaire. (2008) Impact du linézolide sur le microbiote intestinal. Antibiotiques 10:4, pages 192-198.
Crossref
Crossref
Nitin Verma, Ray W. Clarke, Paula H. B. Bolton-Maggs & Hendrik K. F. van Saene. (2007) Gut Overgrowth of Vancomycin-resistant Enterococci (VRE) Results in Linezolid-resistant Mutation in a Child With Severe Congenital Neutropenia. Journal of Pediatric Hematology/Oncology 29:8, pages 557-560.
Crossref
Crossref
Philip Toltzis, Michael Dul, Mary Ann O'Riordan, Hasida Toltzis & Jeffrey L. Blumer. (2007) Comparative Effects of Single-Dose Ceftriaxone Versus Three Oral Antibiotic Regimens on Stool Colonization by Resistant Bacilli in Children. Pediatric Infectious Disease Journal 26:1, pages 25-30.
Crossref
Crossref
E. Myllyluoma, T. Ahlroos, L. Veijola, H. Rautelin, S. Tynkkynen & R. Korpela. (2007) Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota. International Journal of Antimicrobial Agents 29:1, pages 66-72.
Crossref
Crossref
Christoph Högenauer, Cord Langner, Eckhard Beubler, Irmgard T. Lippe, Rudolf Schicho, Gregor Gorkiewicz, Robert Krause, Nikolas Gerstgrasser, Guenter J. Krejs & Thomas A. Hinterleitner. (2006)
Klebsiella oxytoca
as a Causative Organism of Antibiotic-Associated Hemorrhagic Colitis
. New England Journal of Medicine 355:23, pages 2418-2426.
Crossref
Crossref
X. Bertrand, V. Dufour, L. Millon, E. Beuvier, H. Gbaguidi-Haore, R. Piarroux, D.A. Vuitton & D. Talon. (2006) Effect of cheese consumption on emergence of antimicrobial resistance in the intestinal microflora induced by a short course of amoxicillin?clavulanic acid. Journal of Applied Microbiology 0:0, pages 061120055200064-???.
Crossref
Crossref
Minna Rinkinen. 2006. Gastrointestinal Microbiology. Gastrointestinal Microbiology
371
380
.
Åsa Sullivan & Carl Nord. 2006. Gastrointestinal Microbiology. Gastrointestinal Microbiology
335
369
.
Mamie Hui. (2006) An Excellent Pharmacokinetic Profile Can Actually Act as a Double-Edged Sword. Critical Care Medicine 34:1, pages 267-268.
Crossref
Crossref
M. F. De La Cochetière, T. Durand, P. Lepage, A. Bourreille, J. P. Galmiche & J. Doré. (2005) Resilience of the Dominant Human Fecal Microbiota upon Short-Course Antibiotic Challenge. Journal of Clinical Microbiology 43:11, pages 5588-5592.
Crossref
Crossref
Åsa Sullivan, Charlotta Edlund & Carl Erik Nord. 2005. Antimicrobial Agents. Antimicrobial Agents
1357
1370
.
Nicole J. Pultz, Usha Stiefel & Curtis J. Donskey. (2005)
Effects of Daptomycin, Linezolid, and Vancomycin on Establishment of Intestinal Colonization with Vancomycin-Resistant Enterococci and Extended-Spectrum-β-Lactamase-Producing
Klebsiella pneumoniae
in Mice
. Antimicrobial Agents and Chemotherapy 49:8, pages 3513-3516.
Crossref
Crossref
Jeremy K. Nicholson, Elaine Holmes & Ian D. Wilson. (2005) Gut microorganisms, mammalian metabolism and personalized health care. Nature Reviews Microbiology 3:5, pages 431-438.
Crossref
Crossref
H.K.F. van Saene, W.I. Weir, M.A. de la Cal, L. Silvestri, A.J. Petros & S.P. Barrett. (2005) Enteral vancomycin to control MRSA. Journal of Hospital Infection 59:3, pages 263-266.
Crossref
Crossref
H.K.F. van Saene, N.J. Reilly, A. de Silvestre & G. Nardi. 2005. Infection Control in the Intensive Care Unit. Infection Control in the Intensive Care Unit
231
246
.
Sabine Bartosch, Alemu Fite, George T. Macfarlane & Marion E. T. McMurdo. (2004) Characterization of Bacterial Communities in Feces from Healthy Elderly Volunteers and Hospitalized Elderly Patients by Using Real-Time PCR and Effects of Antibiotic Treatment on the Fecal Microbiota. Applied and Environmental Microbiology 70:6, pages 3575-3581.
Crossref
Crossref
Marie Claude Barc, François Bourlioux, Lionel Rigottier-Gois, Céline Charrin-Sarnel, Claire Janoir, Hélène Boureau, Joël Doré & Anne Collignon. (2004) Effect of Amoxicillin-Clavulanic Acid on Human Fecal Flora in a Gnotobiotic Mouse Model Assessed with Fluorescence Hybridization Using Group-Specific 16S rRNA Probes in Combination with Flow Cytometry. Antimicrobial Agents and Chemotherapy 48:4, pages 1365-1368.
Crossref
Crossref
Josette Behra-Miellet, Laurent Calvet & Luc Dubreuil. (2003) Activity of linezolid against anaerobic bacteria. International Journal of Antimicrobial Agents 22:1, pages 28-34.
Crossref
Crossref